Key statistics
On Thursday, Rocket Pharmaceuticals Inc (9IP1:DUS) closed at 19.13, 21.89% above the 52 week low of 15.70 set on Oct 24, 2023.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 18.43 |
---|---|
High | 19.53 |
Low | 18.41 |
Bid | 19.06 |
Offer | 19.19 |
Previous close | 18.53 |
Average volume | 46.90 |
---|---|
Shares outstanding | 90.98m |
Free float | 86.62m |
P/E (TTM) | -- |
Market cap | 1.90bn USD |
EPS (TTM) | -2.79 USD |
Data delayed at least 15 minutes, as of Sep 19 2024 18:32 BST.
More ▼
Press releases
- Rocket Pharmaceuticals Announces Completion of Enrollment in Phase 2 Pivotal Trial of RP-A501 for the Treatment of Danon Disease
- Rocket Pharmaceuticals Announces Appointment of Mikael Dolsten, M.D., Ph.D., to Board of Directors
- Rocket Pharmaceuticals to Participate in Upcoming Investor Conferences
- Rocket Pharmaceuticals Reports Second Quarter 2024 Financial Results and Highlights Recent Progress
- Rocket Pharmaceuticals Provides Regulatory Update on KRESLADI™ (marnetegragene autotemcel; marne-cel)
More ▼